After being downtrending for the last couple of years and market putting in a bottom. See this stock going up much higher and expecting some news about their product on Lucentis biosimilar
Risk Score:
8 out of 10
investment:
Quarterly Holding
Risk Score:
8 out of 10
investment:
Quarterly Holding